LIA
ABBV icon

LBMC Investment Advisors’s AbbVie ABBV Stock Holding History

LBMC Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
6,092
+185
+3% +$39.8K 0.08% 93
2026
Q1 		$1.28M Buy
5,907
+1
+0% +$222 0.08% 95
2025
Q4 		$1.35M Buy
5,906
+61
+1% +$13.9K 0.08% 88
2025
Q3 		$1.35M Buy
5,845
+2,773
+90% +$565K 0.09% 89
2025
Q2 		$570K Hold
3,072
– – 0.04% 118
2025
Q1 		$644K Buy
3,072
+176
+6% +$34.2K 0.05% 103
2024
Q4 		$515K Buy
2,896
+1
+0% +$184 0.04% 118
2024
Q3 		$572K Hold
2,895
– – 0.05% 104
2024
Q2 		$496K Buy
2,895
+1
+0% +$166 0.04% 106
2024
Q1 		$527K Buy
2,894
+61
+2% +$10.5K 0.05% 101
2023
Q4 		$439K Buy
2,833
+1
+0% +$146 0.04% 102
2023
Q3 		$418K Hold
2,832
– – 0.04% 102
2023
Q2 		$381K Buy
2,832
+1
+0% +$147 0.04% 111
2023
Q1 		$451K Buy
2,831
+1
+0% +$153 0.05% 102
2022
Q4 		$457K Sell
2,830
-270
-9% -$41.4K 0.05% 98
2022
Q3 		$416K Hold
3,100
– – 0.05% 98
2022
Q2 		$475K Sell
3,100
-180
-5% -$27.5K 0.05% 82
2022
Q1 		$532K Sell
3,280
-33
-1% -$4.79K 0.05% 90
2021
Q4 		$449K Buy
3,313
+306
+10% +$36.1K 0.04% 104
2021
Q3 		$357K Hold
3,007
– – 0.03% 111
2021
Q2 		$339K Buy
3,007
+1,001
+50% +$113K 0.03% 114
2021
Q1 		$217K Sell
2,006
-10
-0.5% -$1.07K 0.02% 126
2020
Q4 		$216K Buy
+2,016
New +$194K 0.03% 126

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LBMC Investment Advisors's ABBV Position: Q2 2026 in Review

LBMC Investment Advisors increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $39.8K and bringing the position to 6,092 shares worth $1.53M. The position accounts for 0.08% of the portfolio, ranked #93.

LBMC Investment Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LBMC Investment Advisors held 6,092 shares of AbbVie worth $1.53M as of Q2 2026.
  • LBMC Investment Advisors bought 185 AbbVie shares in Q2 2026, an estimated $39.8K.
  • AbbVie made up 0.08% of LBMC Investment Advisors's portfolio in Q2 2026, its #93 holding.
  • LBMC Investment Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LBMC Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.